vimarsana.com

Page 20 - நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How the pioneering science behind the Covid jab could soon offer a new vaccine for cancer

How the pioneering science behind the Covid jab could soon offer a new vaccine for cancer
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.

Exact Therapeutics Abstract on its Phase I ACTIVATE Study to be Presented at the 2021 ASCO Annual Meeting

Exact Therapeutics Abstract on its Phase I ACTIVATE Study to be Presented at the 2021 ASCO Annual Meeting News provided by Share this article Share this article OSLO, Norway and LONDON, May 20, 2021 /PRNewswire/  Exact Therapeutics AS (Euronext Growth: EXTX), a clinical stage precision medicine company utilizing Acoustic Cluster Therapy (ACT®) to harness the power of ultrasound in therapeutic amplification across multiple therapeutic areas and product classes, today announces that an abstract describing the background and methodology of its Phase I study, ACTIVATE, has been released for publication at the 2021 ASCO Annual Meeting. The ACTIVATE Study (NCT04021277) is the first in a series of clinical investigations planned of the Company s Acoustic Cluster Therapy (ACT®) platform technology for targeted therapeutic enhancement.

Cancer patient s charity ride funds breakthrough for drug resistance | News

Scientists predict time before cancer becomes drug resistant – study

Scientists can use genetic “weather forecasting” to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study suggests. Using similar principles to those used in meteorology to predict which mutations might arise, and how they would undergo selection, researchers made long-range forecasts of how cancers might evolve drug resistance. Knowing when drugs are likely to stop working could give clinicians more time to prepare for the next step in a person’s treatment, and to consider offering them alternative therapies or to enrol them in clinical trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.